Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

19.39USD
16 Oct 2018
Change (% chg)

-- (--)
Prev Close
$19.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,419
52-wk High
$23.81
52-wk Low
$7.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-18 2 3.65 5.00 2.30 --
Quarter Ending Jan-19 4 3.67 4.10 3.00 --
Year Ending Apr-18 2 7.25 8.60 5.90 --
Year Ending Apr-19 4 14.80 16.02 12.70 0.30
Year Ending Apr-20 4 20.82 43.80 10.00 30.30
Earnings (per share)
Quarter Ending Apr-18 2 -0.35 -0.26 -0.44 --
Quarter Ending Jan-19 4 -0.50 -0.40 -0.75 --
Year Ending Apr-18 2 -1.84 -1.74 -1.93 --
Year Ending Apr-19 4 -1.90 -1.28 -2.79 -2.88
Year Ending Apr-20 3 -1.99 -0.27 -3.59 -0.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.69
P/E High - Last 5 Yrs. -- 40.57 45.21
P/E Low - Last 5 Yrs. -- 23.31 23.82
Beta -- 0.89 0.88
Price to Sales (TTM) 151.44 3.93 5.82
Price to Book (MRQ) 2.63 4.78 4.90
Price to Tangible Book (MRQ) 2.63 5.61 6.53
Price to Cash Flow (TTM) -- 22.58 22.98
% Owned Institutions 80.82 1.13 2.14

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.39 5.38
Payout Ratio(TTM) -- 46.24 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 2.19 7.73
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.58 5.32
Sales - 5 Yr. Growth Rate -- 9.69 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 19.82 22.57
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.96 10.95
Capital Spending - 5 Yr. Growth Rate -- 15.12 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 7.87 2.97 3.05
LT Debt to Equity (MRQ) 0.80 9.93 12.63
Total Debt to Equity (MRQ) 1.55 13.92 16.96
Interest Coverage (TTM) -29.72 41.53 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.20 54.92
Gross Margin - 5 Yr. Avg. -- 52.31 52.45
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.46 11.10
Operating Margin (TTM) -4,529.25 14.35 4.36
Operating Margin - 5 Yr. Avg. -- 14.35 6.45
Pre-Tax Margin (TTM) -4,120.21 14.89 5.41
Pre-Tax Margin - 5 Yr. Avg. -- 14.80 6.89
Net Profit Margin (TTM) -4,120.21 11.11 1.68
Net Profit Margin - 5 Yr. Avg. -- 11.07 3.14
Effective Tax Rate (TTM) -- 23.35 23.23
Effective Tax Rate - 5 Yr. Avg. -- 23.58 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 912,999,537 812,879,200
Net Income/Employee (TTM) -- 107,437,502 95,609,515
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.61 3.60
Asset Turnover (TTM) 0.01 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.37 10.94
Return on Assets - 5 Yr. Avg. -- 12.62 12.05
Return on Investment (TTM) -60.80 14.77 14.32
Return on Investment - 5 Yr. Avg. -- 16.45 15.66
Return on Equity (TTM) -61.05 16.27 16.04
Return on Equity - 5 Yr. Avg. -- 17.52 16.92
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.92%
# of Holders: 38
Total Shares Held: 10,294,398
3 Mo. Net Change: 3,180,177
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 0
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.